中国药师
中國藥師
중국약사
China Pharmacist
2015年
10期
1750-1752
,共3页
赵展%李卜武%叶欢乐%翟华伟
趙展%李蔔武%葉歡樂%翟華偉
조전%리복무%협환악%적화위
奥美拉唑%谷氨酰胺%应激性溃疡%疗效
奧美拉唑%穀氨酰胺%應激性潰瘍%療效
오미랍서%곡안선알%응격성궤양%료효
Omeprazole%Glutamine%Stress ulcer%Efficacy
目的:观察奥美拉唑联合谷氨酰胺预防应激性溃疡的效果. 方法: 我院ICU收治的重症患者106例根据入院时间先后将患者分成观察组和对照组各53例,对照组患者予谷氨酰胺治疗,观察组患者予奥美拉唑钠联合谷氨酰胺治疗,比较两组患者治疗后胃液pH变化情况、不良反应发生情况和应激性溃疡发病例数. 结果: 治疗4 d后,观察组患者胃液pH明显高于观察组患者(P<0. 05),治疗7 d后两组间差异更大(P<0. 05). 观察组患者治疗后出现的上消化道症状明显少于对照组患者(P<0. 05). 观察组应激性溃疡发病率为5. 66%,明显低于对照组的24. 53%(P<0. 05). 两组药品不良反应发生率比较,差异无统计学意义(P>0. 05). 结论:奥美拉唑联合谷氨酰胺预防应激性溃疡临床疗效好,有效抑制胃酸分泌,快速升高胃液pH,患者应激性溃疡发病率低,不良反应少,值得临床推广.
目的:觀察奧美拉唑聯閤穀氨酰胺預防應激性潰瘍的效果. 方法: 我院ICU收治的重癥患者106例根據入院時間先後將患者分成觀察組和對照組各53例,對照組患者予穀氨酰胺治療,觀察組患者予奧美拉唑鈉聯閤穀氨酰胺治療,比較兩組患者治療後胃液pH變化情況、不良反應髮生情況和應激性潰瘍髮病例數. 結果: 治療4 d後,觀察組患者胃液pH明顯高于觀察組患者(P<0. 05),治療7 d後兩組間差異更大(P<0. 05). 觀察組患者治療後齣現的上消化道癥狀明顯少于對照組患者(P<0. 05). 觀察組應激性潰瘍髮病率為5. 66%,明顯低于對照組的24. 53%(P<0. 05). 兩組藥品不良反應髮生率比較,差異無統計學意義(P>0. 05). 結論:奧美拉唑聯閤穀氨酰胺預防應激性潰瘍臨床療效好,有效抑製胃痠分泌,快速升高胃液pH,患者應激性潰瘍髮病率低,不良反應少,值得臨床推廣.
목적:관찰오미랍서연합곡안선알예방응격성궤양적효과. 방법: 아원ICU수치적중증환자106례근거입원시간선후장환자분성관찰조화대조조각53례,대조조환자여곡안선알치료,관찰조환자여오미랍서납연합곡안선알치료,비교량조환자치료후위액pH변화정황、불량반응발생정황화응격성궤양발병례수. 결과: 치료4 d후,관찰조환자위액pH명현고우관찰조환자(P<0. 05),치료7 d후량조간차이경대(P<0. 05). 관찰조환자치료후출현적상소화도증상명현소우대조조환자(P<0. 05). 관찰조응격성궤양발병솔위5. 66%,명현저우대조조적24. 53%(P<0. 05). 량조약품불량반응발생솔비교,차이무통계학의의(P>0. 05). 결론:오미랍서연합곡안선알예방응격성궤양림상료효호,유효억제위산분비,쾌속승고위액pH,환자응격성궤양발병솔저,불량반응소,치득림상추엄.
Objective:To study the effect of omeprazole combined with glutamine in the prevention of stress ulcer. Methods:To-tally 106 cases of severe patients admitted in ICU of our hospital were divided into the observation group and the control group with 53 ones in each according to the admission order. The patients in the control group were treated with glutamine, and those in the observa-tion group were treated with sodium omeprazole combined with glutamine. The pH change in gastric juice, adverse reactions and inci-dence of stress ulcer after the treatment were observed and compared between the two groups. Results:After the 4-day treatment, the pH value of gastric juice in the observation group was significantly higher than that in the control group (P<0. 05), and after the 7-day treatment, the difference was more notable. After the treatment, the symptoms of upper digestive tract in the observation group were fewer than those in the control group (P<0. 05). After the treatment, the observation group had three stress ulcer patients with the incidence rate of 5. 66%, while that in the control group was higher (24. 53%), and the difference was statistically significant (P<0. 05). There was no statistically significant difference in the adverse reactions between the two groups (P>0. 05). Conclusion:Omeprazole combined with glutamine in the prevention of ulcers stress shows promising clinical efficacy, which can effectively inhibit gastric acid secretion and rapidly increase pH value of gastric juice with low incidence of adverse reactions, mild symptoms and high se-curity, and is worthy of wide use in clinics.